Mapping painDETECT, a neuropathic pain screening tool, to the EuroQol (EQ-5D-3L).

about

Mapping painDETECT, a neuropathic pain screening tool, to the EuroQol (EQ-5D-3L).

Item

http://www.wikidata.org/entity/Q39530911

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Mapping painDETECT, a neuropathic pain screening tool, to the EuroQol (EQ-5D-3L).

@en

Mapping painDETECT, a neuropathic pain screening tool, to the EuroQol (EQ-5D-3L).

@nl

type

Item

label

Mapping painDETECT, a neuropathic pain screening tool, to the EuroQol (EQ-5D-3L).

@en

Mapping painDETECT, a neuropathic pain screening tool, to the EuroQol (EQ-5D-3L).

@nl

prefLabel

Mapping painDETECT, a neuropathic pain screening tool, to the EuroQol (EQ-5D-3L).

@en

Mapping painDETECT, a neuropathic pain screening tool, to the EuroQol (EQ-5D-3L).

@nl

P1476

Mapping painDETECT, a neuropathic pain screening tool, to the EuroQol (EQ-5D-3L).

@en

P2093

Alesia Sadosky

http://www.w3.org/2001/XMLSchema#string

E Jay Bienen

http://www.w3.org/2001/XMLSchema#string

Joseph C Cappelleri

http://www.w3.org/2001/XMLSchema#string

Vijaya Koduru

http://www.w3.org/2001/XMLSchema#string

P2860

Recommendations for the pharmacological management of neuropathic pain: an overview and literature update

Review of studies mapping from quality of life or clinical measures to EQ-5D: an online database

EuroQol--a new facility for the measurement of health-related quality of life

Neuropathic pain phenotyping as a predictor of treatment response in painful diabetic neuropathy: data from the randomized, double-blind, COMBO-DN study.

A cross-sectional cohort survey in 2100 patients with painful diabetic neuropathy and postherpetic neuralgia: Differences in demographic data and sensory symptoms.

EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision.

US valuation of the EQ-5D health states: development and testing of the D1 valuation model.

Estimating the burden of disease in chronic pain with and without neuropathic characteristics: does the choice between the EQ-5D and SF-6D matter?

Health status, function, productivity, and costs among individuals with idiopathic painful peripheral neuropathy with small fiber involvement in the United States: results from a retrospective chart review and cross-sectional survey.

Burden of illness associated with peripheral and central neuropathic pain among adults seeking treatment in the United States: a patient-centered evaluation

P2888

s11136-016-1379-2

P304

467-477

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11136-016-1379-2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-08-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27485915

http://www.w3.org/2001/XMLSchema#string

P921

neuropathic pain